CAS No. |
2259318-52-8 |
|---|---|
中文名称 |
马来酰亚胺-四聚乙二醇-缬氨酸-瓜氨酸-对氨基苄氧羰基-二甲基乙醇胺-PNU-159682 |
英文名称 |
Mal-PEG4-VC-PAB-DMEA-PNU-159682 |
别名 |
Mal-PEG4-VC-PAB-DMEA-PNU-159682 |
标准英文名 |
4-((2S,5S)-25-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-4,7,23-trioxo-2-(3-ureidopropyl)-10,13,16,19-tetraoxa-3,6,22-triazapentacosanamido)benzyl (2-oxo-2-((2S,4S)-2,5,12-trihydroxy-7-methoxy-4-(((1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl)oxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl) ethane-1,2-diylbis(methylcarbamate) |
分子式 |
C74H98N10O27 |
分子量 |
1559.64 |
精确分子量 |
1558.66 |
SMILES |
O([C@@H]1C2=C(C(O)=C3C(=C2O)C(=O)C=4C(C3=O)=CC=CC4OC)C[C@](C(COC(N(CCN(C(OCC5=CC=C(NC([C@@H](NC([C@@H](NC(CCOCCOCCOCCOCCNC(CCN6C(=O)C=CC6=O)=O)=O)C(C)C)=O)CCCNC(N)=O)=O)C=C5)=O)C)C)=O)=O)(O)C1)[C@H]7C[C@@]8(N9[C@](O[C@@]8([C@H](C)O7)[H])([C@@H](OC)OCC9)[H])[H] |
标准SMILES |
CC(C)[C@H](NC(=O)CCOCCOCCOCCOCCNC(=O)CCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)NC1=CC=C(COC(=O)N(C)CCN(C)C(=O)OCC(=O)[C@@]2(O)C[C@H](O[C@H]3C[C@H]4[C@H](O[C@@H]5[C@H](OCCN45)OC)[C@H](C)O3)C3C(O)=C4C(=O)C5=C(C=CC=C5C(=O)C4=C(O)C=3C2)OC)C=C1 |
用途 |
An active molecule-conjugate used in antibody-drug conjugates (ADCs), consisting of the ADC linker Mal-PEG4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682, which incorporates neocarzinostatin-derived chromophore (MMDX) and the cytotoxic agent PNU-159682 for targeted cancer therapy. |
InChIKey |
GIXBUAYRIIAYTE-QIBFXJAHSA-N |
|
|
评论 |
|---|